Conference Reports for NATAP
The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back
Effectiveness of voxilaprevir/velpatasvir/sofosbuvir
in hepatitis C patients previously treated
with direct-acting antiviral agents (DAA)
AASLD Nov 4-8 2022
